ADDITIONAL RESOURCES: Video, hard copy requests, contact information and more available at: http://www.prnewswire.com/broadcast/23684/consumer.html NEW YORK, November 17 /PRNewswire/ -- THIS IS A MULTIVU SPECIAL REPORT BROUGHT TO YOU BY ALLERGAN, INC. THE FDA RECENTLY APPROVED ALLERGAN'S INAMED(R) SILICONE-FILLED BREAST IMPLANTS FOR USE IN BREAST AUGMENTATION, RECONSTRUCTION AND REVISION SURGERY. THE APPROVAL IS A SIGNIFICANT DEVELOPMENT FOR WOMEN IN THE UNITED STATES WHO NOW HAVE THE SAME OPTIONS THAT WOMEN IN MORE THAN 60 COUNTRIES HAVE HAD FOR THE LAST 25 YEARS. DOCTOR PATRICK MAXWELL, PLASTIC SURGEON, NASHVILLE, TENNESSEE AND ASSISTANT CLINICAL PROFESSOR, VANDERBILT UNIVERSITY: "The FDA's approval of Allergan's silicone breast implants is an important milestone in the field of plastic surgery. Now, women seeking breast augmentation, or reconstruction after mastectomy, have more options than ever, which means as a plastic surgeon I'm better able to provide my patients with an individualized result that is unique to their body proportions and in-line with their expectations of surgery." PLEASE VISIT WWW.BREASTIMPLANTSTODAY.COM FOR MORE INFORMATION ON INAMED(R) SILICONE-FILLED BREAST IMPLANTS OR TO FIND AN ALLERGAN SILICONE CERTIFIED PHYSICIAN IN YOUR AREA. I'M DANIELLE ADDAIR. IMPORTANT INAMED(R) SILICONE-FILLED BREAST IMPLANTS SAFETY INFORMATION INAMED(R) SILICONE-FILLED BREAST IMPLANTS ARE INDICATED FOR BREAST AUGMENTATION IN WOMEN 22 YEARS AND OLDER, OR FOR WOMEN UNDERGOING BREAST RECONSTRUCTION OR REVISION SURGERY. IN CLINICAL STUDIES, THE MOST COMMONLY REPORTED ADVERSE EVENTS IN AUGMENTATION PATIENTS AT FOUR YEARS POST-IMPLANTATION WERE: CAPSULAR CONTRACTURE, BREAST PAIN, SWELLING, NIPPLE COMPLICATIONS, IMPLANT MALPOSITION AND IMPLANT RUPTURE. THE MOST COMMONLY REPORTED ADVERSE EVENTS IN RECONSTRUCTION PATIENTS AT FOUR YEARS POST-IMPLANTATION WERE: ASYMMETRY, CAPSULAR CONTRACTURE, SWELLING, WRINKLING AND INFECTION. BREAST IMPLANT SURGERY SHOULD NOT BE PERFORMED IN WOMEN WITH ACTIVE INFECTIONS ANYWHERE IN THEIR BODIES, EXISTING CANCER OR PRE-CANCER OF THEIR BREASTS WHO HAVE NOT RECEIVED ADEQUATE TREATMENT FOR THOSE CONDITIONS OR WHO ARE CURRENTLY PREGNANT OR NURSING. FOR COMPLETE PATIENT SAFETY INFORMATION, PLEASE VISIT WWW.BREASTIMPLANTSTODAY.COM. AUDIO PROVIDED BY: Allergan, Inc. http://www.prnewswire.com/broadcast/23684/consumer.htmlDATASOURCE: Allergan, Inc. CONTACT: FOR STORY INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313, EXT. 3 OR EMAIL Web site: http://www.breastimplantstoday.com/

Copyright